InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001269131-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-06 2026-01-02 PTCT STEELE GLENN JR MD PHD Dir S - Sale+OE $76.35 -12.0K 18.5K -39% -$916.2K
D 2026-01-06 2026-01-02 PTCT STEELE GLENN JR MD PHD Dir M - OptEx $30.86 +12.0K 30.5K +65% +$370.3K
D 2026-01-06 2026-01-02 PTCT STEELE GLENN JR MD PHD Dir A - Grant $0.00 +4,000 22.5K +22% $0
D 2026-01-06 2026-01-02 PTCT STEELE GLENN JR MD PHD Dir M - OptEx $0.00 -12.0K 0 -100% $0
D 2026-01-06 2026-01-02 PTCT STEELE GLENN JR MD PHD Dir A - Grant $0.00 +3,475 3,475 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-01-02 S D 12,000 $76.35 18,500 D — —
2 Common Common Stock 2026-01-02 M A 12,000 $30.86 30,500 D — —
3 Common Common Stock 2026-01-02 A A 4,000 $0.00 22,500 D — — (F2) Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.
4 Derivative Stock Option (Right to Buy) 2026-01-02 M D 12,000 $0.00 0 D $30.86 · — to 2026-01-03 12,000 Common Stock (F3) Currently exercisable.
5 Derivative Stock Option (Right to Buy) 2026-01-02 A A 3,475 $0.00 3,475 D $76.74 · — to 2036-01-01 3,475 Common Stock (F4) This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.